[1]
A. V. Klein, J. Wang, B. G. Feagan, and M. Omoto, “Biosimilars: State of Clinical and Regulatory Science”, J Pharm Pharm Sci, vol. 20, no. 1, pp. 332–348, Jan. 2018.